Absence of nephrotoxicity during cephaloridine therapy for urinary-tract infection.
D000293:Adolescent; D000328:Adult; D001437:Bacteriuria / Q000188:drug therapy; D002509:Cephaloridine / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D004926:Escherichia coli / Q000302:isolation & purification; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007668:Kidney / Q000187:drug effects*; D007709:Klebsiella / Q000302:isolation & purification; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D011511:Proteus / Q000302:isolation & purification; D012008:Recurrence; D012083:Renin / Q000097:blood; D012964:Sodium / Q000097:blood; D014552:Urinary Tract Infections / Q000188:drug therapy*
D012964:Sodium; D012083:Renin; D002509:Cephaloridine; D011188:Potassium